Olmesartan/Amlodipin Al (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin Al, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adult patients. It combines olmesartan with amlodipine, a calcium‑channel blocker, to provide complementary blood‑pressure lowering effects. GNH USA supplies Olmesartan/Amlodipin Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan/Amlodipin Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan/Amlodipin Al is used for hypertension, acting on the renin‑angiotensin system and vascular smooth‑muscle tone.

- Hypertension: improves blood‑pressure control when monotherapy is insufficient. - Chronic kidney disease with hypertension: slows progression of renal impairment. - Heart failure with reduced ejection fraction: assists in afterload reduction as part of combination therapy. - High‑risk cardiovascular patients: lowers the risk of stroke and myocardial infarction when combined with lifestyle measures. - Diabetes‑related hypertension: aids in achieving target blood‑pressure goals in diabetic patients. - Elderly patients with hypertension: provides a once‑daily regimen that is well tolerated.

Common Side Effects: - Headache  -            ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

Serious or Rare Side Effects:\n-  ....  ....  .... .... .... .... .... .... .... ...  .... .... .... .... .... .... ....

Olmes5  t    g  .... .... .... ...